Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma
Clinical trial NCT01206296 · TERMINATED
Trial details
- NCT number
- NCT01206296
- Sponsor
- Medstar Health Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2014-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.